middle.news
ImpediMed Reports 23% Revenue Growth Amid Rising Losses in FY2025
1:49am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
ImpediMed Reports 23% Revenue Growth Amid Rising Losses in FY2025
1:49am on Saturday 30th of August, 2025 AEST
Key Points
Revenue increased 23% to $12.7 million
Net loss after tax rose 17% to $23.2 million
No dividends declared or paid during FY2025
Net tangible assets per security fell to 0.37 cents
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Impedimed (ASX:IPD)
OPEN ARTICLE